Press "Enter" to skip to content

Lupin gets tentative nod from USFDA to market its Fosaprepitant injection

The company has received tentative approval from the the United States Food and Drug Administration (USFDA) to market its Fosaprepitant for injection in the strength of 150 mg single-dose vial, Lupin said in a statement.

Original source: https://health.economictimes.indiatimes.com/news/pharma/lupin-gets-tentative-nod-from-usfda-to-market-its-fosaprepitant-injection/69218449?utm_source=RSS&utm_medium=ETRSS